Riskpilot← Back to searchSign inGet full accessLINDBERG CONSULTING AS
ASActiveOrg 985725667Bygdøy Allé 33A, 0262 OsloGeneral medical practice activities · NACE 8621Est. 20032 employeeswww.fedon.no
Revenue 2024
NOK 354K
+4% vs 2023
EBITDA margin
70.6%
+921% vs 2023
Equity ratio
95.5%
Financial strength
Net profit 2024
NOK 594K
+2983% vs 2023
| Revenue | NOK 354K | +4% |
| EBITDA | NOK 250K | +921% |
| Net profit | NOK 594K | +2983% |
| Total assets | NOK 2,7M | +34% |
| Equity | NOK 2,6M | +29% |
| Employees | 2 | — |
Legal name
LINDBERG CONSULTING AS
Org number
985725667
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
27. mai 2003
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Utføre legevirksomhet, tilby kurs og foredrag, konsulenttjenester innenfor helse og matvareteknologi, produktutvikling, klinisk forskning, grafisk arbeid, omsetning av kunstgjenstander samt annen virksomhet som står i sammenheng med dette, herunder også deltagelse i andre selskap med lignende formål.
Address
Bygdøy Allé 33A, 0262 Oslo
Website
www.fedon.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 792 | 772 | 546 | 342 | 354 |
| Staff expenses | −7 | −106 | 104 | −41 | −65 |
| EBITDA | 638 | 563 | 998 | −30 | 250 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 638 | 563 | 998 | −30 | 250 |
| Net financials | −626 | 22 | 82 | 10 | 344 |
| Profit before tax | 12 | 585 | 1 081 | −21 | 594 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 12 | 585 | 1 081 | −21 | 594 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 177 | 1 569 | 2 210 | 2 042 | 2 739 |
| Equity | 827 | 1 113 | 2 043 | 2 023 | 2 617 |
| Long-term debt | 90 | 0 | 0 | 0 | 0 |
| Short-term debt | 260 | 456 | 167 | 19 | 122 |
| Total debt | 350 | 456 | 167 | 19 | 122 |
EBITDA margin
70.6%
This company
15.8%
Market median
+347% vs market
20202024
Equity ratio
95.5%
This company
38.2%
Market median
+150% vs market
20202024
Return on equity
22.7%
This company
18.4%
Market median
+23% vs market
20202024
Net profit margin
167.9%
This company
8.1%
Market median
+1973% vs market
20202024
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20202024
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KL Deputy Member | Deputy Member | 2003 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2003 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LINDBERG CONSULTING AS (this company)
NUTRISTON ASBoard members of LINDBERG CONSULTING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kenneth Lindberg | Deputy Member | 0 companies |
| Fedon Alexander Lindberg | Chairman | 0 companies |